CN Stock MarketDetailed Quotes

688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.

Watchlist
  • 26.67
  • +0.15+0.57%
Market Closed Apr 30 15:00 CST
5.04BMarket Cap21.60P/E (TTM)

Jiangsu Jibeier Pharmaceutical Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
17.47%194.23M
31.49%860.93M
44.64%616.97M
62.83%418.81M
19.10%165.34M
28.46%654.73M
16.29%426.57M
2.56%257.21M
15.61%138.82M
-9.94%509.69M
Operating revenue
17.47%194.23M
31.49%860.93M
44.64%616.97M
62.83%418.81M
19.10%165.34M
28.46%654.73M
16.29%426.57M
2.56%257.21M
15.61%138.82M
-9.94%509.69M
Total operating cost
9.25%134.01M
24.26%609.49M
25.47%431.84M
38.01%302.13M
15.61%122.67M
22.36%490.5M
18.24%344.19M
10.30%218.92M
16.34%106.11M
-7.36%400.87M
Operating cost
3.48%20.43M
24.93%95.15M
34.02%68.59M
46.14%46.45M
23.39%19.75M
22.62%76.17M
13.78%51.18M
5.91%31.79M
15.68%16M
-3.04%62.12M
Operating tax surcharges
127.05%2.87M
13.36%10.47M
41.74%7.27M
17.09%4.51M
-34.25%1.26M
1.57%9.24M
-25.61%5.13M
-17.73%3.85M
-16.83%1.92M
-8.06%9.1M
Operating expense
10.38%87.66M
29.26%401.87M
31.27%280.73M
50.88%200.24M
10.79%79.42M
19.51%310.91M
14.25%213.85M
4.05%132.72M
16.14%71.68M
-9.18%260.16M
Administration expense
-0.81%14.03M
14.49%57.99M
9.78%42.08M
8.91%27.77M
31.17%14.14M
13.85%50.65M
22.27%38.33M
21.22%25.5M
23.84%10.78M
10.40%44.49M
Financial expense
-53.69%-673.78K
-1.16%-11.78M
-45.52%-8.93M
-32.24%-5.46M
66.55%-438.4K
-172.37%-11.65M
-97.23%-6.13M
-129.32%-4.13M
-57.70%-1.31M
-183.07%-4.28M
-Interest expense (Financial expense)
-93.44%56.77K
-71.95%105.53K
-62.09%65.44K
-62.89%64.06K
--865.17K
--376.23K
--172.62K
--172.62K
----
----
-Interest Income (Financial expense)
42.95%-758.2K
0.54%-12.02M
-43.15%-9.1M
-28.77%-5.57M
-0.31%-1.33M
-175.93%-12.09M
-98.74%-6.35M
-132.55%-4.33M
-53.06%-1.33M
-169.56%-4.38M
Research and development
13.62%9.7M
1.08%55.77M
0.63%42.1M
-2.01%28.6M
21.42%8.53M
88.44%55.18M
75.68%41.83M
71.90%29.19M
28.64%7.03M
-12.71%29.28M
Credit Impairment Loss
142.42%827.87K
-883.43%-7.2M
-181.27%-6.27M
-318.95%-7.66M
-572.97%-1.95M
-141.40%-732.27K
-37.57%-2.23M
-757.48%-1.83M
-145.23%-289.98K
157.25%1.77M
Asset Impairment Loss
----
---2.02M
----
----
----
----
----
----
----
----
Other net revenue
Invest income
-157.64%-2.14M
-133.46%-1.9M
-196.19%-2.83M
-136.20%-1.42M
-101.83%-828.72K
-67.08%5.68M
-69.65%2.94M
-51.48%3.92M
---410.6K
-3.46%17.26M
-Including: Investment income associates
-28.96%-1.4M
8.78%-5.55M
13.23%-3.97M
18.93%-2.49M
29.29%-1.09M
-80.34%-6.09M
-4,200.51%-4.58M
---3.07M
---1.54M
---3.37M
Asset deal income
----
----
----
----
----
----
---9.79K
----
----
----
Other revenue
211.45%721.14K
21.73%8.79M
-82.76%1.08M
-92.21%436.24K
-56.05%231.54K
24.95%7.22M
34.73%6.27M
152.65%5.6M
-72.20%526.8K
127.92%5.78M
Operating profit
48.62%59.63M
41.22%249.11M
98.23%177.12M
134.96%108.04M
23.31%40.13M
32.00%176.4M
1.03%89.35M
-26.91%45.98M
3.61%32.54M
-11.24%133.63M
Add:Non operating Income
----
-92.49%458.64
----
----
----
--6.1K
--1.5K
--1.5K
----
----
Less:Non operating expense
-10.68%144.53K
-12.61%1.64M
-66.01%449.76K
104.36%315.36K
607.54%161.8K
74.71%1.87M
53.83%1.32M
-61.54%154.32K
-93.88%22.87K
-47.29%1.07M
Total profit
48.86%59.49M
41.79%247.48M
100.69%176.67M
135.05%107.72M
22.90%39.96M
31.66%174.53M
0.52%88.03M
-26.69%45.83M
4.79%32.52M
-10.75%132.56M
Less:Income tax cost
243.47%7.06M
41.63%28.71M
140.79%21.88M
196.55%11.65M
-49.17%2.06M
11.29%20.27M
-22.71%9.09M
-45.40%3.93M
-5.21%4.04M
-2.44%18.22M
Net profit
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
-11.94%114.35M
Net profit from continuing operation
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
-11.94%114.35M
Less:Minority Profit
17.92%-84.48K
20.87%-320.31K
11.08%-279.55K
9.07%-191.9K
8.40%-102.93K
26.96%-404.79K
26.57%-314.38K
36.71%-211.04K
47.81%-112.36K
-496.98%-554.18K
Net profit of parent company owners
38.15%52.51M
41.65%219.09M
95.65%155.07M
128.59%96.26M
32.98%38.01M
34.61%154.67M
3.94%79.26M
-24.33%42.11M
5.95%28.58M
-11.42%114.9M
Earning per share
Basic earning per share
40.00%0.28
40.96%1.17
97.62%0.83
121.74%0.51
33.33%0.2
36.07%0.83
2.44%0.42
-23.33%0.23
7.14%0.15
-20.78%0.61
Diluted earning per share
40.00%0.28
40.96%1.17
97.62%0.83
121.74%0.51
33.33%0.2
36.07%0.83
2.44%0.42
-23.33%0.23
7.14%0.15
-20.78%0.61
Other composite income
Total composite income
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
-11.94%114.35M
Total composite income of parent company owners
38.15%52.51M
41.65%219.09M
95.65%155.07M
128.59%96.26M
32.98%38.01M
34.61%154.67M
3.94%79.26M
-24.33%42.11M
5.95%28.58M
-11.42%114.9M
Total composite income of minority owners
17.92%-84.48K
20.87%-320.31K
11.08%-279.55K
9.07%-191.9K
8.40%-102.93K
26.96%-404.79K
26.57%-314.38K
36.71%-211.04K
47.81%-112.36K
-496.98%-554.18K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 17.47%194.23M31.49%860.93M44.64%616.97M62.83%418.81M19.10%165.34M28.46%654.73M16.29%426.57M2.56%257.21M15.61%138.82M-9.94%509.69M
Operating revenue 17.47%194.23M31.49%860.93M44.64%616.97M62.83%418.81M19.10%165.34M28.46%654.73M16.29%426.57M2.56%257.21M15.61%138.82M-9.94%509.69M
Total operating cost 9.25%134.01M24.26%609.49M25.47%431.84M38.01%302.13M15.61%122.67M22.36%490.5M18.24%344.19M10.30%218.92M16.34%106.11M-7.36%400.87M
Operating cost 3.48%20.43M24.93%95.15M34.02%68.59M46.14%46.45M23.39%19.75M22.62%76.17M13.78%51.18M5.91%31.79M15.68%16M-3.04%62.12M
Operating tax surcharges 127.05%2.87M13.36%10.47M41.74%7.27M17.09%4.51M-34.25%1.26M1.57%9.24M-25.61%5.13M-17.73%3.85M-16.83%1.92M-8.06%9.1M
Operating expense 10.38%87.66M29.26%401.87M31.27%280.73M50.88%200.24M10.79%79.42M19.51%310.91M14.25%213.85M4.05%132.72M16.14%71.68M-9.18%260.16M
Administration expense -0.81%14.03M14.49%57.99M9.78%42.08M8.91%27.77M31.17%14.14M13.85%50.65M22.27%38.33M21.22%25.5M23.84%10.78M10.40%44.49M
Financial expense -53.69%-673.78K-1.16%-11.78M-45.52%-8.93M-32.24%-5.46M66.55%-438.4K-172.37%-11.65M-97.23%-6.13M-129.32%-4.13M-57.70%-1.31M-183.07%-4.28M
-Interest expense (Financial expense) -93.44%56.77K-71.95%105.53K-62.09%65.44K-62.89%64.06K--865.17K--376.23K--172.62K--172.62K--------
-Interest Income (Financial expense) 42.95%-758.2K0.54%-12.02M-43.15%-9.1M-28.77%-5.57M-0.31%-1.33M-175.93%-12.09M-98.74%-6.35M-132.55%-4.33M-53.06%-1.33M-169.56%-4.38M
Research and development 13.62%9.7M1.08%55.77M0.63%42.1M-2.01%28.6M21.42%8.53M88.44%55.18M75.68%41.83M71.90%29.19M28.64%7.03M-12.71%29.28M
Credit Impairment Loss 142.42%827.87K-883.43%-7.2M-181.27%-6.27M-318.95%-7.66M-572.97%-1.95M-141.40%-732.27K-37.57%-2.23M-757.48%-1.83M-145.23%-289.98K157.25%1.77M
Asset Impairment Loss -------2.02M--------------------------------
Other net revenue
Invest income -157.64%-2.14M-133.46%-1.9M-196.19%-2.83M-136.20%-1.42M-101.83%-828.72K-67.08%5.68M-69.65%2.94M-51.48%3.92M---410.6K-3.46%17.26M
-Including: Investment income associates -28.96%-1.4M8.78%-5.55M13.23%-3.97M18.93%-2.49M29.29%-1.09M-80.34%-6.09M-4,200.51%-4.58M---3.07M---1.54M---3.37M
Asset deal income ---------------------------9.79K------------
Other revenue 211.45%721.14K21.73%8.79M-82.76%1.08M-92.21%436.24K-56.05%231.54K24.95%7.22M34.73%6.27M152.65%5.6M-72.20%526.8K127.92%5.78M
Operating profit 48.62%59.63M41.22%249.11M98.23%177.12M134.96%108.04M23.31%40.13M32.00%176.4M1.03%89.35M-26.91%45.98M3.61%32.54M-11.24%133.63M
Add:Non operating Income -----92.49%458.64--------------6.1K--1.5K--1.5K--------
Less:Non operating expense -10.68%144.53K-12.61%1.64M-66.01%449.76K104.36%315.36K607.54%161.8K74.71%1.87M53.83%1.32M-61.54%154.32K-93.88%22.87K-47.29%1.07M
Total profit 48.86%59.49M41.79%247.48M100.69%176.67M135.05%107.72M22.90%39.96M31.66%174.53M0.52%88.03M-26.69%45.83M4.79%32.52M-10.75%132.56M
Less:Income tax cost 243.47%7.06M41.63%28.71M140.79%21.88M196.55%11.65M-49.17%2.06M11.29%20.27M-22.71%9.09M-45.40%3.93M-5.21%4.04M-2.44%18.22M
Net profit 38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M-11.94%114.35M
Net profit from continuing operation 38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M-11.94%114.35M
Less:Minority Profit 17.92%-84.48K20.87%-320.31K11.08%-279.55K9.07%-191.9K8.40%-102.93K26.96%-404.79K26.57%-314.38K36.71%-211.04K47.81%-112.36K-496.98%-554.18K
Net profit of parent company owners 38.15%52.51M41.65%219.09M95.65%155.07M128.59%96.26M32.98%38.01M34.61%154.67M3.94%79.26M-24.33%42.11M5.95%28.58M-11.42%114.9M
Earning per share
Basic earning per share 40.00%0.2840.96%1.1797.62%0.83121.74%0.5133.33%0.236.07%0.832.44%0.42-23.33%0.237.14%0.15-20.78%0.61
Diluted earning per share 40.00%0.2840.96%1.1797.62%0.83121.74%0.5133.33%0.236.07%0.832.44%0.42-23.33%0.237.14%0.15-20.78%0.61
Other composite income
Total composite income 38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M-11.94%114.35M
Total composite income of parent company owners 38.15%52.51M41.65%219.09M95.65%155.07M128.59%96.26M32.98%38.01M34.61%154.67M3.94%79.26M-24.33%42.11M5.95%28.58M-11.42%114.9M
Total composite income of minority owners 17.92%-84.48K20.87%-320.31K11.08%-279.55K9.07%-191.9K8.40%-102.93K26.96%-404.79K26.57%-314.38K36.71%-211.04K47.81%-112.36K-496.98%-554.18K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg